Anti-Cancer Drugs
@Anti_CancerDrug
Followers
160
Following
9
Media
4
Statuses
1K
Internationally refereed #journal devoted to the fast #publication of innovative investigations into #therapeutic agents against #cancer
Joined August 2012
RT @MedicineLWW: Learn how to create a publication-ready manuscript with one of Lippincott's leading Editorial experts, Duncan A. MacRae.….
0
6
0
The 2019 #impactfactor shined on us, check out our bio for our new score. We're ever so thankful to our authors and reviewers and celebrate this good news with you too. Check out our latest issue for all our very citable content 😊.
0
0
1
RT @BibliotecaHUVH: Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors #….
pubmed.ncbi.nlm.nih.gov
Accessible prognostic tools are needed to individualize treatment of neuroendocrine tumors (NETs). Data suggest neutrophil/lymphocyte ratios (NLRs) have prognostic value in some solid tumors,...
0
1
0
RT @DrNJNasser: Some good things come from the Subterranean Blind Mole Rat @Anti_CancerDrug @UofHaifa @TechnionLive..
0
1
0
RT @NeuroEndoTalk: Recent interest has focused on #neutrophil/#lymphocyte ratios (NLRs) as a prognostic. In #NETs, NLRs are not prognostic….
0
1
0
Check out our bio for our 2018 #impactfactor while it's still fresh. And in the immortal words of MC Hammer, you can't touch this 🔥.Except you guys can, submit your papers here:.
1
0
1
Our marketing team are looking at what your colleagues are reading and to get you reading it too this paper is free:.Clinical management of localized undifferentiated sinonasal carcinoma.#chemotherapy #radiotherapy #carcinoma .#whatyourcolleagueisreading.
0
0
1
Efficacy and safety of #raltitrexed -based #transarterial chemoembolization for #colorectal #cancer #liver #metastases 👉🏾We've made this paper free to view online until February. Go, take a look!.
0
0
0
Have you checked out our #openaccess #paper in the latest issue? We hope it doesn't make you dizzy 🙃.
0
0
2
If this figure makes sense to you, we 👏🏾 you. If you want to find out more, check out the #preclinical #report:
0
0
0
Have you published with us? Let us know, we'd love to hear from you!.
0
0
0
We took a break from Twitter, but we're back now. Here's a pre-clinical report from us to you:
0
0
0
Thyroid cancer management: from a suspicious nodule to targeted therapy
0
0
1
Ginsenoside Rg1 impairs homologous recombination repair by targeting CtBP-interacting protein and sensitizes hepatoblastoma cells to DNA damage
0
0
1
PAP: Prognostic role of the cumulative toxicity in patients affected by metastatic renal cells carcinoma and .
0
0
0
PAP: Pachymic acid inhibits the tumorigenicity of gastric cancer cells by the mitochondrial pathway.: Pachymi.
0
0
0
PAP: Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in.
0
0
0
PAP: Trabectedin in advanced desmoplastic round cell tumors: a retrospective single-center series.: Desmopla.
0
0
0
PAP: Efficacy and safety of recombinant human adenovirus p53 combined with chemoradiotherapy in the treatment.
0
0
0
PAP: Irradiated VEGF164-modified tumor cell vaccine protected mice from the parental tumor challenge.: Vascul.
0
0
0